We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
+13.2%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$216M
AUM Growth
+$40.9M
Cap. Flow
+$30.7M
Cap. Flow %
14.18%
Top 10 Hldgs %
40.9%
Holding
110
New
40
Increased
20
Reduced
11
Closed
36

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$6.41M
2
BIIB icon
Biogen
BIIB
+$4.44M
3
CI icon
Cigna
CI
+$3.91M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$3.61M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$3.18M

Top Sells

Rank Stock Value
1
ARTC
ARTHROCARE CORP
ARTC
+$3.56M
2
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$3.4M
3
GILD icon
Gilead Sciences
GILD
+$2.74M
4
ITMN
INTERMUNE INC
ITMN
+$2.21M
5
DXCM icon
DexCom
DXCM
+$2.13M

Sector Composition

Rank Sector Weight
1 Healthcare 64.65%
2 Industrials 0.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WMGI
26
DELISTED
Wright Medical Group Inc
WMGI
$3.11M 1.44%
100,000
+30,000
+43% +$946K
INCY icon
27
Incyte
INCY
$24.5B
$3.08M 1.42%
57,500
-17,500
-23% -$1.09M
ALXN
28
DELISTED
Alexion Pharmaceuticals
ALXN
$3.04M 1.41%
+20,000
New +$3.18M
BMRN icon
29
CALL
BioMarin Pharmaceuticals
BMRN
$13.5B
$2.73M 1.26%
+40,000
New +$2.95M
RARE icon
30
Ultragenyx Pharmaceutical
RARE
$2.66B
$2.69M 1.24%
+55,000
New +$2.83M
CYTK icon
31
Cytokinetics
CYTK
$10.6B
$2.66M 1.23%
280,000
+130,000
+87% +$1.18M
TEVA icon
32
CALL
Teva Pharmaceuticals
TEVA
$42.5B
$2.64M 1.22%
+50,000
New +$2.31M
TEVA icon
33
Teva Pharmaceuticals
TEVA
$42.5B
$2.64M 1.22%
+50,000
New +$2.31M
IPXL
34
CALL
DELISTED
Impax Laboratories, Inc.
IPXL
$2.64M 1.22%
100,000
+50,000
+100% +$1.25M
ELGX
35
DELISTED
Endologix Inc
ELGX
$2.48M 1.15%
19,250
+3,250
+20% +$505K
LH icon
36
CALL
Labcorp
LH
$26.1B
$2.46M 1.13%
+29,100
New +$2.32M
ETRM
37
DELISTED
EnteroMedics Inc.
ETRM
$2.09M 0.97%
1,095
+24
+2% +$56.8K
ESPR
38
DELISTED
Esperion Therapeutics
ESPR
$2.04M 0.94%
135,000
-15,000
-10% -$233K
ECYT
39
DELISTED
Endocyte, Inc. Common Stock
ECYT
$1.79M 0.83%
+75,000
New +$1.09M
BRKR icon
40
Bruker
BRKR
$8.69B
$1.71M 0.79%
75,000
+10,000
+15% +$218K
BMRN icon
41
BioMarin Pharmaceuticals
BMRN
$13.5B
$1.71M 0.79%
+25,000
New +$1.84M
VNDA icon
42
Vanda Pharmaceuticals
VNDA
$298M
$1.63M 0.75%
+100,000
New +$1.42M
GWPH
43
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$1.48M 0.69%
+25,000
New +$1.49M
FLXN
44
DELISTED
Flexion Therapeutics, Inc.
FLXN
$1.48M 0.68%
+90,000
New +$1.56M
TSRO
45
DELISTED
TESARO, Inc.
TSRO
$1.47M 0.68%
50,000
+35,000
+233% +$1.1M
ASRT
46
DELISTED
Assertio
ASRT
$1.45M 0.67%
1,667
+584
+54% +$445K
LSTA icon
47
Lisata Therapeutics
LSTA
$10.9M
$1.41M 0.65%
1,333
-1,334
-50% -$1.45M
EGLT
48
DELISTED
Egalet Corporation
EGLT
$1.4M 0.65%
+100,000
New +$1.45M
NVS icon
49
CALL
Novartis
NVS
$294B
$1.27M 0.59%
+16,740
New +$1.22M
LJPC
50
DELISTED
La Jolla Pharmaceutical Company
LJPC
$1.22M 0.56%
+112,500
New +$1.1M
1
2
3 4 5

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q1 2014 Portfolio in Review

As of Q1 2014, Iguana Healthcare Management held 110 positions worth $216M, up 23% from $175M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Iguana Healthcare Management deployed $30.7M of net new capital in Q1 2014, opening 40 new positions and adding to 20 existing holdings. Its largest new stake was Medtronic: 110,000 shares worth $6.77M.

By sector, the portfolio is most concentrated in Healthcare at 65% of assets, up from 61% a quarter earlier, followed by Industrials.

On the sell side, the largest reduction was Gilead Sciences, an estimated $2.74M trimmed.

  • Iguana Healthcare Management's largest Q1 2014 buy was Medtronic: 110,000 shares worth $6.77M.
  • Iguana Healthcare Management added most to Biogen in Q1 2014, an estimated $4.44M increase.
  • Iguana Healthcare Management's biggest Q1 2014 reduction was Gilead Sciences, cutting an estimated $2.74M.
  • Iguana Healthcare Management fully exited ARTHROCARE CORP in Q1 2014, selling an estimated $3.56M.
  • Iguana Healthcare Management's ten largest holdings make up 41% of its $216M portfolio in Q1 2014.
  • Iguana Healthcare Management opened 40 new positions and closed 36 in Q1 2014.
  • Iguana Healthcare Management's portfolio value rose 23% quarter-over-quarter to $216M.

Based on Iguana Healthcare Management's 13F filing for Q1 2014, filed 16 May 2014.